Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02343718
Title Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors NCIC Clinical Trials Group
Indications

Advanced Solid Tumor

lymphoma

high grade glioma

Therapies

Temsirolimus + Vinblastine

Age Groups: child
Covered Countries CAN


No variant requirements are available.